Every Cure News Today

Penn researchers received a $48 million grant from the White House for AI-powered research that matches existing drugs to rare diseases without a treatment.  

BioPhy and Every Cure announced a strategic partnership to revolutionize drug repurposing through artificial intelligence (AI).

The Philadelphia healthcare nonprofit is developing a knowledge graph to predict which existing treatments could have wider application

Around six weeks ago, University of Pennsylvania medical professor David Fajgenbaum received a call from the family of a man in Washington state who was dying from a rare blood

Over the past few years, Every Cure has developed a blueprint for an AI-powered platform that can do what humans can’t — match thousands of diseases with thousands of drugs.

Every Cure, a nonprofit on a mission to save lives by repurposing existing medicines, announced today...

/PRNewswire/ -- Every Cure, a nonprofit on a mission to save lives by repurposing existing medicines, announced today significant funding from the Advanced...

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence and insights, today announced…

David Fajgenbaum, MD, MBA, MSc, cofounder of Every Cure, shared that the organization is able to reduce clinical trial costs to $1 to $5 million per drug trial, and that clinical trials are not always necessary to expand a drug's indication.

Leaders from Every Cure and Moonshots for Unicorns highlight their work toward finding treatments for rare diseases currently without a cure.